Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus

OBJECTIVE: To compare the treatment outcomes of sorafenib plus transarterial chemoembolization (TACE) vs TACE alone in patients with hepatocellular carcinoma (HCC) and hepatic vein tumor thrombus (HVTT). METHODS: Twenty patients who were initially diagnosed with HCC and HVTT and received TACE combin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yong-Fa, Wei, Wei, Wang, Jia-Hong, Xu, Li, Jian, Pei-En, Xiao, Cheng-Zuo, Zhong, Xiao-Ping, Shi, Ming, Guo, Rong-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948732/
https://www.ncbi.nlm.nih.gov/pubmed/27471398
http://dx.doi.org/10.2147/OTT.S106659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948732/
https://www.ncbi.nlm.nih.gov/pubmed/27471398
http://dx.doi.org/10.2147/OTT.S106659

Ejemplares similares